EPTIFIBATIDE INJECTION Solution

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Eptifibatide

MAH:

TEVA CANADA LIMITED

ATC_code:

B01AC16

INN:

EPTIFIBATIDE

dosage:

0.75MG

pharmaceutical_form:

Solution

composition:

Eptifibatide 0.75MG

administration_route:

Intraveineuse

units_in_package:

100ML

prescription_type:

Prescription

therapeutic_area:

PLATELET AGGREGATION INHIBITORS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0137621001; AHFS:

authorization_status:

ANNULÉ APRÈS COMMERCIALISATION

authorization_date:

2018-04-30